Article Information
History
- January 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Pedro Henrique Gazzinelli-Guimaraes1,*,
- Gayatri Sanku1,*,
- Alessandro Sette2,
- Daniela Weiskopf2,
- Paul Schaughency3,
- Justin Lack3 and
- Thomas B. Nutman1,#
- 1Laboratory of Parasitic Diseases, NIAID, National Institutes of Health, USA
- 2Center for Infectious Disease, La Jolla Institute for Immunology, USA
- 3Frederick National Laboratory for Cancer Research, National Institutes of Health, USA
- ↵#Corresponding author: Thomas B. Nutman, 4 Center Dr. Room 211, National Institutes of Health, Bethesda, MD, 20892-0425, Tel: 301-496-5399, e-mail: tnutman{at}niaid.nih.gov
↵* These authors contributed equally to this paper
Posted January 21, 2022.
Antigenic determinants of SARS-CoV-2-specific CD4+ T cell lines reveals M protein-driven dysregulation of interferon signaling
